Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions
Pancreatic ductal adenocarcinoma (PDAC) continues to rise in incidence and remains one of the deadliest solid tumors due to its insidious onset and extremely poor overall survival. Current therapeutic options—surgery, chemotherapy, and radiotherapy—offer limited benefit for most patients, largely be...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-03-01
|
| Edice: | Frontiers in Oncology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1756245/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|